Age-Related Macular Degeneration

Artificial intelligence has potential to facilitate accurate, frequent and larger-scale home monitoring of chronic ocular diseases when safely integrated into workflows, according to a review published in Current Opinion in Ophthalmology.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Quan Dong Nguyen, MD, MSc, shares the latest achievements in two areas: intermediate age-related macular degeneration and Stargardt disease.

ROME — In this Healio Video Perspective at the FLORetina-ICOOR meeting, Giuseppe Querques, MD, PhD, discusses phenotypes of intermediate AMD that help physicians predict geographic atrophy development and progression.

ROME — In this Healio Video Perspective at the FLORetina-ICOOR meeting, James G. Fujimoto, PhD, speaks about advancements in high resolution spectral-domain OCT.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Michael Stewart, MD, speaks about aflibercept 8 mg, the newly approved version of Eylea.

In this video, Esther M. Bowie, MD, discusses results of the GALE study, presented at the American Academy of Ophthalmology meeting.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Albert Augustin, MD, speaks about the beneficial effects of metformin on age-related macular degeneration.

Dec. 5 is World Geographic Atrophy Day, a new initiative that seeks to empower individuals with this advanced form of dry age-related macular degeneration and expand global advocacy, education and support efforts.

In this video, Yasha S. Modi, MD, discusses the Charles L. Schepens, MD, Lecture presented at the American Academy of Ophthalmology meeting by Emily Y. Chew, MD, on macular telangiectasia.

In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Sophie J. Bakri, MD, discusses outcomes from the FARETINA-AMD study of faricimab as a treatment for age-related macular degeneration.